WIF-1 gene methylation in cervical squamous intraepithelial lesions
- Авторлар: Sukhikh G.T.1, Ashrafyan L.A.2, Bairamova G.R.1, Babkina I.O.3, Chernova V.F.1, Osipyants A.I.3, Korolkova A.I.1, Poloznikov A.A.3, Asfarova G.R.1, Mullabaeva S.M.1, Kogan E.A.4, Muizhnek E.L.5, Drukh V.M.6, Kiselev V.I.2
-
Мекемелер:
- Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia
- D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University
- ZAO “MiraxBioFarma”
- Peoples’ Friendship University of Russia
- Шығарылым: № 5 (2017)
- Беттер: 114-123
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247975
- DOI: https://doi.org/10.18565/aig.2017.5.114-23
- ID: 247975
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
Gennady Sukhikh
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: g_sukhikh@oparina4.ru
Doctor of Medical Sciences, Professor, Academician of the Russian Academy of Sciences, Director
Lev Ashrafyan
Russian Research Center of Roentgenology and Radiology, Ministry of Health of RussiaDoctor of Medical Sciences, Honored Doctor of the Russian Federation, Professor, Head of the Laboratory of Combined Methods for the Treatment of Gynecological Diseases
Gyuldana Bairamova
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: g_bairamova@oparina4.ru
doctor of medical sciences, head of the clinical work of the scientific and polyclinic department of the Clinical Department
Irina Babkina
D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Health of Russia
Email: iobabkina@gmail.com
laboratory assistant-researcher of the laboratory of infectious immunology
Viktoria Chernova
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: v_chernova@oparina4.ru
post-graduate student of the polyclinic department
Andrey Osipyants
D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Health of Russia
Email: osssip@gmail.com
researcher, Laboratory of Biochemistry and Enzymology
Anna Korolkova
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: zaikinaai@icloud.com
post-graduate student of the I year of training
Andrey Poloznikov
D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Health of Russia
Email: andrey.poloznikov@gmail.com
Candidate of Chemical Sciences, Head of the Laboratory of Biochemistry and Enzymology
Gunay Asfarova
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: gunyt@mail.ru
Post-graduate student of the I year of training
Svetlana Mullabaeva
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: s_mullabaeva@oparina4.ru
the head of the laboratory for the collection and storage of biomaterials
Evgenia Kogan
I.M. Sechenov First Moscow State Medical University
Email: expedition@mma.ru
Doctor of Medical Sciences, Professor, Academician A.I. Strukov Department of Pathological Anatomy
Ekaterina Muizhnek
ZAO “MiraxBioFarma”
Email: MuyzhnekEL@ilmixgroup.ru
Candidate of Biological Sciences, Director for Science
Vadim Drukh
Peoples’ Friendship University of Russia
Email: druhvm@gmail.com
Candidate of Medical Sciences, Head of Scientific Projects, Institute of Biomedical Problems
Vsevolod Kiselev
Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia
Email: vkisl0@mail.ru
Doctor of Biological Sciences, Professor, Corresponding Member. RAS, Chief Scientific Officer of the Research Department of Early Carcinogenesis, Prevention, Diagnosis and Comprehensive Treatment of Oncological Diseases of Female Reproductive Organs
Әдебиет тізімі
- Zaravinos A., Mammas I.N., Sourvinos G., Spandidos D.A. Molecular detection methods of human papillomavirus (HPV). Int. J. Biol. Markers. 2009; 24(4): 215-22.
- Коган Е.А., Файзуллина Н.М., Ли Ц., Демура Т.А., Жарков Н.В., Козаченко А.В., Байрамова Г.Р., Чернова В.Ф., Прилепская В.Н. Ранняя диагностика ВПЧ-ассоциированной патологии шейки матки у женщин до 30 лет и старше. Акушерство и гинекология. 2015; 9: 62-7. [Kogan E.A., Faizullina N.M., Li Ts., Demura T.A., Zharkov N.V., Kozachenko A.V., Chernova V.F., Bairamova G.R., Prilepskaya V.N. Early diagnosis of HPV-associated disease of the cervix uteri in women aged less than 30 years or older. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2015; (9): 62-7. (in Russian)
- Blatt A.J., Kennedy R., Luff R.D., Austin R.M., Rabin D.S. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices. Cancer Cytopathol. 2015; 123(5): 282-8. doi: 10.1002/ cncy.21544.
- Байрамова Г.Р., Файзуллин Л.З., Королькова А.И., Полозников А.А., Киселев В.И. Скрининг рака шейки матки: что нового в мировой практике? Акушерство и гинекология. 2016; 7: 17-21. http://dx.doi.org/ 10.18565/aig.2016.7.17-21 [Bairamova G.R., Faizullin L.Z., Korolkova A.I., Poloznikov A.A., Kiselev V.I. Cervical cancer screening: What is new in global practice? Akusherstvo i ginekologiya/ Obstetrics and Gynecology. 2016; (7): 17-21. (in Russian) http://dx.doi. org/10.18565/aig.2016.7.17-21]
- Киселев В.И. Молекулярные механизмы патогенеза гиперпластических и диспластических заболеваний репродуктивной системы и пути их фармакологической коррекции. В кн.: Прилепская В.Н., ред. Патология шейки матки и генитальные инфекции. М.: МЕДпресс-информ; 2008: 53-60. [Kiselev V.I. Molecular mechanisms of pathogenesis of hyperplastic and dysplastic diseases of the reproductive system and ways of their pharmacological correction. In: Prilepskaya V.N., ed. Cervical pathology and genital infections. Мoscow: MEDpress-inform; 2008: 53-60. (in Russian)]
- Boyer S.N., Wazer D.E., Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996; 56(20): 4620-4.
- Thomas M., Pim D., Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene. 1999; 18(53): 7690-700. doi: 10.1038/sj.onc.1202953.
- Uren A., Fallen S., Yuan H., Usubütün A., Küçükali T., Schlegel R. et al. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res. 2005; 65(14): 6199-206. doi: 10.1158/0008-5472.CAN-05-0455.
- Curtin J.C., Lorenzi M.V. Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget. 2010; 1(7): 552-66. doi: 10.18632/ oncotarget.101016.
- Hsieh J.C., Kodjabachian L., Rebbert M.L., Rattner A., Smallwood P.M., Samos C.H. et al. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature. 1999; 398(6726): 431-6. doi: 10.1038/ 18899.
- Ai L., Tao Q., Zhong S., Fields C.R., Kim W.-J., Lee M.W. et al. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis. 2006; 27: 1341-8. doi: 10.1093/carcin/bgi379.
- Yee D.S., Tang Y., Li X., Liu Z., Guo Y., Ghaffar S. et al. The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition. Mol. Cancer. 2010; 9: 162. doi: 10.1186/ 1476-4598-9-162.
- Delmas A.L., Riggs B.M., Pardo C.E., Dyer L.M., Darst R.P., Izumchenko E.G. et al. WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix. Carcinogenesis. 2011; 32: 1625-33. doi: 10.1093/carcin/bgr193.
- Ramachandran I., Thavathiru E., Ramalingam S., Natarajan G., Mills W.K., Benbrook D.M. et al. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene. 2012; 31(22): 2725-37. doi: 10.1038/onc.2011.455.
- Urakami S., Shiina H., Enokida H., Hirata H., Kawamoto K., Kawakami T. et al. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin. Cancer Res. 2006; 12(23): 6989-97. doi: 10.1158/1078-0432.CCR-06-1194.
- Issa J.P Cancer prevention: epigenetics steps up to the plate. Cancer Prev. Res. (Phila) 2008; 1(4): 219-22. doi: 10.1158/1940-6207.CAPR-08-0029.
- Esteller M. Epigenetics in cancer. N. Engl. J. Med. 2008; 358(11): 1148-59. doi: 10.1056/NEJMra072067.
- Laird P.W. Cancer epigenetics. Hum. Mol. Genet. 2005; 14(Spec No): R65-76. doi: 10.1093/hmg/ddi113.
- Deng Y., Yu B., Cheng Q., Jin J., You H., Ke R. et al. Epigenetic silencing of WIF-1 in hepatocellular carcinomas. J. Cancer Res. Clin. Oncol. 2010; 136(8): 1161-7. doi: 10.1007/s00432-010-0763-5.
- Gao Z., Xu Z., Hung M-S., Lin Y-C., Wang T., Gong M. et al. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Anticancer Res. 2009; 29(6): 2025-30.
- Kumaki Y., Oda M., Okano M. QUMA: quantification tool for methylation analysis. Nucleic. Acids Res. 2008; 36: W170-5. doi: 10.1093/nar/ gkn294.
- Van Der Meide W.F., Snellenberg S., Meijer C.J.L.M., Baalbergen A., Helmerhorst T.J.M., Van Der Sluis W.B. et al. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix. Gynecol. Oncol. 2011; 123(1): 116-22. doi: 10.1016/j.ygyno.2011.06.015.
- Kan Y.-Y., Liou Y.-L., Wang H.-J., Chen C.-Y., Sung L.-C., Chang C.-F. et al. PAX1 Methylation as a Potential Biomarker for Cervical Cancer Screening. Int. J. Gynecol. Cancer. 2014; 24: 928-34. doi: 10.1097/ IGC.0000000000000155.
- Kato K., Long N.K., Makita H., Toida M., Yamashita T., Hatakeyama D. et al. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br. J. Cancer. 2008; 99: 647-54. doi: 10.1038/sj.bjc.6604521.